ROSACEA DEVELOPMENT | TRIGGER CONTROL | REDNESS CONTROL
THREAD VEINS & TISSUE CHANGES | UK EVALUATION
THREAD VEINS & TISSUE CHANGES | UK EVALUATION
REDNESS CONTROL
Erythema Reduction
In the Scientific overview you will have read about the processes affected by Synchrorose®. This clinical study demonstrated the visible outcome of using the product.
Synchrorose® has been through medical studies carried out by top dermatologists in the field of rosacea and below is a summary of the results of one study which shows rapid reductions in erythema (reddening and swelling).
Here are some photos taken before and after 10 days of some of the actual patients in the experiment.
Reduction in Anti-Inflammatory Chemicals like Interleukin-1-Alpha
Various chemicals are released by the skin in response to triggering, exacerbating the skin's response. The key ingredients in Synchrorose® have been shown to reduce the amount of inflammatory agents released when stimulated. In the experiment below, an inflammatory-triggering chemical known as SLS was used and you can see in that the key active ingredients in Synchrorose® Fast reduced the amount released and this was sustained over time.
